Anti-GPC1 mAb strongly inhibited tumor growth via antibody-dependent cellular cytotoxicity dependent and independent manner in GPC1-positive ESCC xenograft models. This evidence concerns the gene GPC1 and esophageal squamous cell carcinoma.